Recent advances in dietary androgen receptor inhibitors

Li Ren1, Tiehua Zhang1, Jie Zhang1

  • 1College of Food Science and Engineering, Jilin University, Changchun, China.

PubMed

Insights

Dietary intake of natural compounds can inhibit the androgen receptor (AR), potentially reducing the risk of prostate diseases like cancer. This review explores natural AR inhibitors for nutritional intervention.

Area of Science:

  • Endocrinology and Molecular Biology
  • Nutritional Science
  • Oncology

Background:

  • The androgen receptor (AR) is vital for male development and prostate health, but its dysregulation contributes to prostatic diseases, including prostate cancer.
  • Epidemiological studies suggest dietary factors, such as green tea and soy, may lower prostate cancer risk.
  • Current synthetic antiandrogens have limitations, driving the search for alternative therapies.

Purpose of the Study:

  • To review the structure and function of the androgen receptor (AR).
  • To elucidate the mechanisms of action for existing antiandrogens.
  • To summarize research on natural AR inhibitors from dietary sources and their potential role in preventing prostatic diseases.

Main Methods:

  • Literature review of experimental, epidemiological, and clinical studies.
  • Analysis of the structural basis for AR antagonism.
  • Focus on natural compounds from edible plants, folk medicines, and supplements.

Main Results:

  • Natural compounds from edible plants and traditional medicines act as AR inhibitors.
  • Dietary intake of natural antiandrogens is associated with a reduced risk of prostatic diseases.
  • Natural products present advantages over synthetic antiandrogens.

Conclusions:

  • Natural AR inhibitors offer a promising avenue for nutritional intervention against prostatic disorders.
  • Further research into dietary-derived AR inhibitors could lead to novel strategies for managing prostate health.
  • This review provides an updated overview of natural antiandrogens for preventing prostate diseases.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
809
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
323
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K